On Nov. 19, Payward Inc., the operator of the crypto exchange, announced that it has confidentially submitted a draft ...

Summit Therapeutics' Ivonescimab targets non-small cell lung cancer through its dual anti-PD-1 plus anti-VEGF mechanism.

For decades the US had the technological lead, and no one really came close, but recently China has been threatening its ...

Vizsla Silver Corp. ("Vizsla Silver" or the "Company") announces its intention to offer convertible senior unsecured notes due 2031 (the "Notes") in an aggregate principal amount of US$250 million ...

Mike Selig, the nominee to be the next chairman of the Commodity Futures Trading Commission, testified at his confirmation ...

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Recent developments indicate a dual focus on regulatory reform for public companies, with the SEC Chairman Paul Atkins prioritizing public offering reforms and President Donald Trump signaling renewed ...